← back to search

Humam Kadara

The University of Texas MD Anderson Cancer Center · US
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, and Cancer Genomics and Diagnostics.
h-index
53
citations
10,611
works
526
NIH funding
primary concept
Medicine
email

Recent publications

Translating premalignant biology to accelerate non-small-cell lung cancer interception
Nature reviews. Cancer 2025cited by 22position: middledoi
Multimodal spatial-omics reveal co-evolution of alveolar progenitors and proinflammatory niches in progression of lung precursor lesions
Cancer Cell 2025cited by 12position: lastdoi
Cellular senescence in precancer lesions and early-stage cancers
Cancer Cell 2025cited by 4position: middledoi
An atlas of epithelial cell states and plasticity in lung adenocarcinoma
Nature 2024cited by 155position: lastdoi
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics
Nature Communications 2024cited by 19position: middledoi
Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement
American Journal of Respiratory and Critical Care Medicine 2024cited by 17position: middledoi
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Nature Medicine 2023cited by 467position: middledoi
Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA
Cell Systems 2023cited by 92position: middledoi
Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma
Cancer Research 2023cited by 19position: middledoi
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma
Cancer Discovery 2022cited by 152position: middledoi
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Nature Communications 2021cited by 216position: middledoi
Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing
Cancer Discovery 2021cited by 128position: lastdoi
Comprehensive T cell repertoire characterization of non-small cell lung cancer
Nature Communications 2020cited by 228position: middledoi
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development
American Journal of Respiratory and Critical Care Medicine 2020cited by 46position: lastdoi
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer
American Journal of Respiratory and Critical Care Medicine 2019cited by 35position: firstdoi
Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma
Cancer Research 2017cited by 125position: lastdoi
microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis
Scientific Reports 2017cited by 42position: middledoi
Distinct pattern of <i>TP53</i> mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma
Cancer 2017cited by 28position: middledoi
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
Annals of Oncology 2016cited by 209position: firstdoi
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
Annals of Oncology 2016cited by 118position: middledoi
Genomic Landscape Established by Allelic Imbalance in the Cancerization Field of a Normal Appearing Airway
Cancer Research 2016cited by 50position: lastdoi
Transcriptomic Architecture of the Adjacent Airway Field Cancerization in Non–Small Cell Lung Cancer
JNCI Journal of the National Cancer Institute 2014cited by 85position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Junya Fujimoto · The University of Texas MD Anderson Cancer Center5 papers (2014–2019)Steven M. Dubinett · APLA Health5 papers (2017–2025)Ignacio I. Wistuba · Disco (Germany)5 papers (2014–2019)Neda Kalhor · The University of Texas MD Anderson Cancer Center4 papers (2014–2019)César A. Moran · The University of Texas MD Anderson Cancer Center4 papers (2014–2019)Avrum Spira · Johnson & Johnson (United States)4 papers (2014–2023)Stephen G. Swisher · The University of Texas MD Anderson Cancer Center3 papers (2016–2019)Carmen Behrens · University of Illinois Chicago3 papers (2016–2019)John V. Heymach · 1The University of Texas MD Anderson Cancer Center3 papers (2016–2019)Ramin Salehi‐Rad · National Institutes of Health2 papers (2023–2024) · 2 papers (2017–2019)Paul Scheet · Medical College of Wisconsin2 papers (2017–2019)Jennifer Beane · Boston University2 papers (2023–2024)Joseph Schlessinger · Yale University2 papers (2016–2016)Jeffrey P. Townsend · Yale University2 papers (2016–2016)Jianjun Zhang · Northwestern Polytechnical University2 papers (2017–2019)Jing Wang · IHS Markit (United States)2 papers (2017–2019)F. Anthony San Lucas · The University of Texas MD Anderson Cancer Center2 papers (2017–2019)Chi‐Wan Chow · The University of Texas MD Anderson Cancer Center2 papers (2014–2016)Wenhua Lang · Weifang Medical University2 papers (2017–2019)